Alymphocytosis – Severe Combined Immune Deficiency (SCID) News and Information

What is Alymphocytosis?  (Definition)

Severe combined immunodeficiency, SCID, also known as alymphocytosis, Glanzmann–Riniker syndrome, severe mixed immunodeficiency syndrome, and thymic alymphoplasia, is a rare genetic disorder identified by the disturbed development of functional T cells and B cells caused by numerous genetic mutations that result in heterogeneous clinical presentations. The condition is also referred to as bubble boy disease and bubble baby disease because its victims are extremely vulnerable to infectious diseases.

See below for updated news and information regarding Alymphocytosis – Severe Combined Immune Deficiency (SCID) including new research, treatments and advancements. 

Latest Alymphocytosis – Severe Combined Immune Deficiency (SCID) News

SCID Research News: Research Cracks Genetic Driver of Patient’s Rare Immune Disorder

(SOURCE: UC SAN FRANCISCO) By Nicholas Weiler on November 30, 2016. Study Demonstrates Power of Precision Genomics to Understand Unique Causes of Disease in Individual Patients. A UC San Francisco-led research team has identified the rare genetic mutation responsible for a unique case of severe combined immunodeficiency (SCID), a deadly immune system disorder also known as “boy in the bubble” disease. In ...
Read More

IQWiG assesses benefit of newborn screening for severe combined

News-Medical.netJan 30, 2017
The benefit assessment provides a hint of a benefit of newborn screening for SCID: An early test combined with infection prophylaxis and …

First non-human primate model for severe combined

Medical XpressDec 24, 2016
Researchers from Japan and the US have generated the first ever non-human primate models for X-linked severe combined immunodeficiency …
 .

Newborn screening identifies unknown cause of severe combined

Clinical AdvisorDec 5, 2016
(HealthDay News) — Mutant BCL11B has been identified as a cause of severecombined immunodeficiency (SCID) in newborn screening, …
 .

Can Parents Refuse a Potentially Lifesaving Transplant for Severe

AAP NewsJun 15, 2016
Although potentially lifesaving, prognosis of HSCT in SCID is variable depending on a number of host and donor factors. Of the survivors, many develop …
 .

‘Molecular scissors’ could point the way to genetic cures

Phys.OrgJan 18, 2017
Current SCD treatments are lifelong and can have severe side effects. … the DNA that triggers severe combined immunodeficiency disease, …